Matthew W. Reynolds, PhD
Executive Director
Epidemiology and Database Analytics
Matthew W. Reynolds, PhD, is the Executive Director of UBC's Center for Epidemiology and Database Analytics (CEDA). Dr. Reynolds oversees epidemiology, database, and safety projects at UBC and acts as a principal investigator or advisor on many safety-related and pharmacoepidemiology-based projects such as systematic literature reviews and meta-analysis, individual patient database analyses, prospective epidemiology studies, and risk management and drug safety consulting. He is currently the founder and chair of the Database Special Interest Group for the International Society of Pharmacoepidemiology.
Prior to joining UBC, Dr. Reynolds was the Senior Director of Risk Management and Safety Services at MetaWorks, Inc., which was acquired by UBC in January 2006. His industry expertise is critical in defining research questions and drafting study protocols, directing analyses, and delivering project findings. He has held prior positions with AstraZeneca as Associate Director of Cardiovascular Epidemiology, Pharmacia Corporation (formerly Searle Pharmaceutical) as a Pharmacoepidemiologist and Senior Analyst, and numerous assignments for the School of Medicine at the University of Maryland (Baltimore). As a pharmacoepidemiologist at Pharmacia and AstraZeneca, Dr. Reynolds designed protocols for a variety of epidemiology studies that spanned the spectrum of diseases in patient populations, their risk factors, and the effectiveness and safety of those treatments. Dr. Reynolds has published multiple papers in the area of cardiology, hematology, and infectious disease, and has conducted over 80 scientific presentations and workshops on study results and on various epidemiological methods over the past 10 years.
Dr. Reynolds earned his graduate and doctoral degrees in epidemiology and preventive medicine from the University of Maryland at Baltimore.
